Key Takeaways
Key players operating in the IGBT and Super Junction MOSFET market includes Pfizer Inc. (U.S.), ARGON MEDICAL (U.S.), Edwards Lifesciences Corporation (U.S.), BD (U.S.), Alcaliber S.A. (Spain), Lupin Pharmaceuticals, Inc. (India), Vitaltec Corporation (China), Medtronic (U.S.), Koninklijke Philips N.V. (The Netherlands), Siemens Healthcare GmbH (Germany), Hitachi Medical Corporation (U.S.), and Canon Medical Systems Corporation (Japan). Key players are focusing on developing IGBT and super junction MOSFET semiconductor products with higher current ratings and switching frequencies to meet the evolving demands from EV, renewable energy and industrial motor control sectors.

The global demand for IGBT And Super Junction MOSFET Market Demand is expected to grow significantly during the forecast period owing to the increasing adoption of electric vehicles worldwide. As more countries formulate policies to ban petrol/diesel vehicles and promote electric mobility, the sale of EVs is projected to rise exponentially, thereby driving the need for related power electronics components.

Moreover, key players are expanding their IGBT and MOSFET manufacturing capabilities globally to establish themselves as a leading supplier. For instance, major players like Infineon, Mitsubishi, and STMicroelectronics have set up additional wafer fabs and assembly lines across Asia Pacific, Europe and North America to cater to the growing international demand.

Get more insights, On IGBT and Super Junction MOSFET Market